Array-818-202 for Non-small Cell Lung Cancer - Clinical Trial
What is the Purpose of this Study?
If you choose to join this study, you will:
-Be in the study up to 2 years
-Take study drugs daily
-Give blood samples
-Possible give a small lung tissue sample
-Continue with your regular care
Non-Small Cell Lung Cancer (NSCLC)
Who Can Participate in the Study?
Adults 19 years or older with NSCLC with a gene called BRAFV600E that has mutated.
What is Involved?
We are doing this study to learn about the safety and effectiveness of the study drugs (Encorafenib and Binimetinib) in patients.